Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABAA receptor α1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion

Neuroscience

Volumn 154, Issue 3, 2008, Pages 1088-1099

  Yamamoto, N ^a   Soghomonian, J J ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

6 hydroxydopamine; basal ganglia; dopamine D1 receptor; GABA; glutamic acid decarboxylase; striatum

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; GLUTAMATE DECARBOXYLASE; MESSENGER RNA; OXIDOPAMINE; PREPRODYNORPHIN; PREPROENKEPHALIN; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; DRUG EFFECT; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; AUTORADIOGRAPHY; BENZAZEPINES; DOPAMINE AGONISTS; GLUTAMATE DECARBOXYLASE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MAZINDOL; NEOSTRIATUM; NEURONS; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RNA, MESSENGER; STIMULATION, CHEMICAL; SUBSTANTIA NIGRA; SYMPATHECTOMY, CHEMICAL; SYMPATHOLYTICS;

EID: 46549083590     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.04.015     Document Type: Article

References (55)

1. Andersson M., Hilbertson A., and Cenci M.A. Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease. Neurobiol Dis 6 (1999) 461-474
2. Bacci J.J., Salin P., and Kerkerian-Le Goff L. Systemic administration of dizocilpine maleate (MK-801) or L-dopa reverses the increases in GAD65 and GAD67 mRNA expression in the globus pallidus in a rat hemiparkinsonian model. Synapse 46 (2002) 224-234
3. Bernath S., and Zigmond M.J. Dopamine may influence striatal GABA release via three separate mechanisms. Brain Res 476 (1989) 373-376
4. Carey R.J. Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance. Brain Res 568 (1991) 205-214
5. Carta A., Fenu S., and Morelli M. Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson's disease. Neurol Sci 22 (2001) 59-60
6. Carta A.R., Pinna A., Cauli O., and Morelli M. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats. Synapse 44 (2002) 166-174
7. Carta A.R., Fenu S., Pala P., Tronci E., and Morelli M. Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats. Eur J Neurosci 18 (2003) 2563-2572
8. Carta A.R., Tronci E., Pinna A., and Morelli M. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment. Eur J Neurosci 21 (2005) 1196-1204
9. Chadha A., Dawson L.G., Jenner P.G., and Duty S. Effect of unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway on GABA(A) receptor subunit gene expression in the rodent basal ganglia and thalamus. Neuroscience 95 (2000) 119-126
10. Consolo S., Morelli M., Rimoldi M., Giorgi S., and Di Chiara G. Increased striatal expression of glutamate decarboxylase 67 after priming of 6-hydroxydopamine-lesioned rats. Neuroscience 89 (1999) 1183-1187
11. Doucet J.P., Nakabeppu Y., Bedard P.J., Hope B.T., Nestler E.J., Jasmin B.J., Chen J.S., Iadarola M.J., St-Jean M., Wigle N., Blanchet P., Grondin R., and Robertson G.S. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. Eur J Neurosci 8 (1996) 365-381
12. Erlander M.G., Tillakaratne N.J., Feldblum S., Patel N., and Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron 7 (1991) 91-100
13. Ferre S., O'Connor W.T., Svenningsson P., Bjorklund L., Lindberg J., Tinner B., Stromberg I., Goldstein M., Ogren S.O., Ungerstedt U., Fredholm B.B., and Fuxe K. Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopenduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms. Eur J Neurosci 8 (1996) 1545-1553
14. Gerfen C.R., and Young III W.S. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res 460 (1988) 161-167
15. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., and Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
16. Gerfen C.R., Miyachi S., Paletzki R., and Brown P. D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase. J Neurosci 22 (2002) 5042-5054
17. Gnanalingham K.K., and Robertson R.G. Chronic continuous and intermittent L-3,4-dihydroxyphenylalanine treatments differentially affect basal ganglia function in 6-hydroxydopamine lesioned rats: an autoradiographic study using [3H]flunitrazepam. Neuroscience 57 (1993) 673-681
18. Hsu C.C., Thomas C., Chen W., Davis K.M., Foos T., Chen J.L., Wu E., Floor E., Schloss J.V., and Wu J.Y. Role of synaptic vesicle proton gradient and protein phosphorylation on ATP-mediated activation of membrane-associated brain glutamate decarboxylase. J Biol Chem 274 (1999) 24366-24371
19. Jin H., Wu H., Osterhaus G., Wei J., Davis K., Sha D., Floor E., Hsu C.C., Kopke R.D., and Wu J.Y. Demonstration of functional coupling between gamma-aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. Proc Natl Acad Sci U S A 100 (2003) 4293-4298
20. Katz J., Nielsen K.M., and Soghomonian J.J. Comparative effects of acute or chronic administration of levodopa to 6-hydroxydopamine-lesioned rats on the expression of glutamic acid decarboxylase in the neostriatum and GABAA receptors subunits in the substantia nigra, pars reticulata. Neuroscience 132 (2005) 833-842
21. Kaufman D.L., Houser C.R., and Tobin A.J. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem 56 (1991) 720-723
22. Lantin le Boulch N., Truong-Ngoc N.A., Gauchy C., and Besson M.J. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons. Brain Res 559 (1991) 200-210
23. Laprade N., and Soghomonian J.J. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Brain Res Mol Brain Res 34 (1995) 65-74
24. Laprade N., and Soghomonian J.J. Glutamate decarboxylase (GAD65) gene expression is increased by dopamine receptor agonists in a subpopulation of rat striatal neurons. Brain Res Mol Brain Res 48 (1997) 333-345
25. Laprade N., and Soghomonian J.J. Gene expression of the GAD67 and GAD65 isoforms of glutamate decarboxylase is differentially altered in subpopulations of striatal neurons in adult rats lesioned with 6-OHDA as neonates. Synapse 33 (1999) 36-48
26. Le Moine C., and Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355 (1995) 418-426
27. Lindefors N., Brene S., Herrera-Marschitz M., and Persson H. Region specific regulation of glutamic acid decarboxylase mRNA expression by dopamine neurons in rat brain. Exp Brain Res 77 (1989) 611-620
28. Liu J., Tai C., de Groat W.C., Peng X.M., Mata M., and Fink D.J. Release of GABA from sensory neurons transduced with a GAD67-expressing vector occurs by non-vesicular mechanisms. Brain Res 1073-1074 (2006) 297-304
29. Martin D.L., and Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem 60 (1993) 395-407
30. Mercugliano M., Soghomonian J.J., Qin Y., Nguyen H.Q., Feldblum S., Erlander M.G., Tobin A.J., and Chesselet M.F. Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases (Mr 65,000 and Mr 67,000) in the basal ganglia of the rat. J Comp Neurol 318 (1992) 245-254
31. Morelli M., and Di Chiara G. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning. Eur J Pharmacol 141 (1987) 101-107
32. Morelli M., Fenu S., Garau L., and Di Chiara G. Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. Eur J Pharmacol 162 (1989) 329-335
33. Nielsen K.M., and Soghomonian J.J. Normalization of glutamate decarboxylase gene expression in the entopeduncular nucleus of rats with a unilateral 6-hydroxydopamine lesion correlates with increased GABAergic input following intermittent but not continuous levodopa. Neuroscience 123 (2004) 31-42
34. Pan H.S., Penney J.B., and Young A.B. Gamma-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle. J Neurochem 45 (1985) 1396-1404
35. Pavon N., Martin A.B., Mendialdua A., and Moratalla R. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice. Biol Psychiatry 59 (2006) 64-74
36. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, San Diego
37. Robertson G.S., Vincent S.R., and Fibiger H.C. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49 (1992) 285-296
38. Rouillard C., Bedard P., Falardeau P., and Di Paolo T. Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion. Eur J Pharmacol 157 (1988) 125-133
39. Schoffelmeer A.N., Vanderschuren L.J., De Vries T.J., Hogenboom F., Wardeh G., and Mulder A.H. Synergistically interacting dopamine D1 and NMDA receptors mediate nonvesicular transporter-dependent GABA release from rat striatal medium spiny neurons. J Neurosci 20 (2000) 3496-3503
40. Smith Y., Bevan M.D., Shink E., and Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86 (1998) 353-387
41. Soghomonian J.J., Gonzales C., and Chesselet M.F. Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons. Brain Res 576 (1992) 68-79
42. Soghomonian J.J., Pedneault S., Audet G., and Parent A. Increased glutamate decarboxylase mRNA levels in the striatum and pallidum of MPTP-treated primates. J Neurosci 14 (1994) 6256-6265
43. Soghomonian J.J., Laprade N., Sandstrom M., and Bruno J.P. c-fos Gene expression is induced in a subpopulation of striatal neurons following a single administration of a dopamine D1-receptor agonist in adult rats lesioned with 6-OHDA as neonates. Brain Res Mol Brain Res 57 (1998) 155-160
44. Soghomonian J.J., and Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol Sci 19 (1998) 500-505
45. Surmeier D.J., Yan Z., and Song W.J. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. Adv Pharmacol 42 (1998) 1020-1023
46. Tanaka Y., Niijima K., Mizuno Y., and Yoshida M. Changes in gamma-aminobutyrate, glutamate, aspartate, glycine, and taurine contents in the striatum after unilateral nigrostriatal lesions in rats. Exp Neurol 91 (1986) 259-268
47. Tossman U., Segovia J., and Ungerstedt U. Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydopamine-lesioned rats measured with microdialysis. Acta Physiol Scand 127 (1986) 547-551
48. Valastro B., Andersson M., Lindgren H.S., and Cenci M.A. Expression pattern of JunD after acute or chronic L-DOPA treatment: comparison with deltaFosB. Neuroscience 144 (2007) 198-207
49. Wang H., Katz J., Dagostino P., and Soghomonian J.J. Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata. Neuroscience 145 (2007) 727-737
50. Weiss L.T., and Chesselet M.F. Regional distribution and regulation of preprosomatostatin messenger RNA in the striatum, as revealed by in situ hybridization histochemistry. Mol Brain Res 5 (1989) 121-130
51. Wu H., Jin Y., Buddhala C., Osterhaus G., Cohen E., Jin H., Wei J., Davis K., Obata K., and Wu J.Y. Role of glutamate decarboxylase (GAD) isoform, GAD65, in GABA synthesis and transport into synaptic vesicles-Evidence from GAD65-knockout mice studies. Brain Res 1154 (2007) 80-83
52. Wu Y., Richard S., and Parent A. The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neurosci Res 38 (2000) 49-62
53. Yamamoto N., Pierce R.C., and Soghomonian J.J. Subchronic administration of L-DOPA to adult rats with a unilateral 6-hydroxydopamine lesion of dopamine neurons results in a sensitization of enhanced GABA release in the substantia nigra, pars reticulata. Brain Res 1123 (2006) 196-200
54. Yoshikawa K., Williams C., and Sabol S.L. Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system. J Biol Chem 259 (1984) 14301-14308
55. You Z.B., Herrera-Marschitz M., Nylander I., Goiny M., O'Connor W.T., Ungerstedt U., and Terenius L. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis-II. Effects of dopamine D1 and D2 receptor agonists. Neuroscience 63 (1994) 427-434